Pharming Group to participate in August investor conference
Pharming Group (NASDAQ:PHAR) announced its participation in the upcoming Canaccord Genuity 45th Annual Growth Conference in Boston, USA. CEO Fabrice Chouraqui will deliver a presentation on Tuesday, August 12, 2025, at 12:00 PM EDT/18:00 CEST.
Investors interested in one-on-one meetings with Pharming's management team can arrange them through the company's Investor Relations team or their Canaccord Genuity representative.
Pharming Group (NASDAQ:PHAR) ha annunciato la sua partecipazione alla prossima 45陋 Conferenza Annuale sulla Crescita di Canaccord Genuity che si terr脿 a Boston, USA. Il CEO Fabrice Chouraqui terr脿 una presentazione il marted矛 12 agosto 2025, alle 12:00 EDT/18:00 CEST.
Gli investitori interessati a incontri individuali con il team di gestione di Pharming possono organizzarli tramite il team Relazioni con gli Investitori della societ脿 o il loro rappresentante Canaccord Genuity.
Pharming Group (NASDAQ:PHAR) anunci贸 su participaci贸n en la pr贸xima 45陋 Conferencia Anual de Crecimiento de Canaccord Genuity en Boston, EE. UU. El CEO Fabrice Chouraqui realizar谩 una presentaci贸n el martes 12 de agosto de 2025, a las 12:00 PM EDT/18:00 CEST.
Los inversores interesados en reuniones individuales con el equipo directivo de Pharming pueden coordinarlas a trav茅s del equipo de Relaciones con Inversores de la empresa o su representante de Canaccord Genuity.
Pharming Group (NASDAQ:PHAR)臧� 氙戈淡 氤挫姢韯挫棎靹� 鞐措Μ電� Canaccord Genuity 鞝�45須� 鞐半 靹膘灔 旎嵓霟办姢鞐� 彀戈皜頃滊嫟瓿� 氚滍憸頄堨姷雼堧嫟. CEO鞚� Fabrice Chouraqui臧� 2025雲� 8鞗� 12鞚� 頇旍殧鞚� 鞓ろ泟 12:00 EDT/18:00 CEST鞐� 氚滍憸毳� 歆勴枆頃� 鞓堨爼鞛呺媹雼�.
Pharming 瓴届榿歆勱臣 1:1 氙疙寘鞚� 頋頃橂姅 韴瀽鞛愲姅 須岇偓鞚� 韴瀽鞛� 甏�瓿勴寑 霕愲姅 Canaccord Genuity 雼措嫻鞛愲ゼ 韱淀暣 氙疙寘鞚� 臁办湪頃� 靾� 鞛堨姷雼堧嫟.
Pharming Group (NASDAQ:PHAR) a annonc茅 sa participation 脿 la 45e conf茅rence annuelle sur la croissance de Canaccord Genuity qui se tiendra 脿 Boston, aux 脡tats-Unis. Le PDG Fabrice Chouraqui fera une pr茅sentation le mardi 12 ao没t 2025, 脿 12h00 EDT/18h00 CEST.
Les investisseurs souhaitant organiser des r茅unions individuelles avec l'茅quipe de direction de Pharming peuvent les planifier via l'茅quipe des relations investisseurs de la soci茅t茅 ou leur repr茅sentant Canaccord Genuity.
Pharming Group (NASDAQ:PHAR) gab seine Teilnahme an der bevorstehenden 45. j盲hrlichen Wachstums-Konferenz von Canaccord Genuity in Boston, USA, bekannt. CEO Fabrice Chouraqui wird am Dienstag, den 12. August 2025, um 12:00 Uhr EDT/18:00 Uhr CEST eine Pr盲sentation halten.
Investoren, die an Einzelgespr盲chen mit dem Management von Pharming interessiert sind, k枚nnen diese 眉ber das Investor-Relations-Team des Unternehmens oder ihren Canaccord Genuity-Ansprechpartner arrangieren.
- None.
- None.
Leiden, the聽Netherlands, August 4, 2025: Pharming Group N.V. (鈥淧harming鈥�) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming鈥檚 management will participate in the following investor conference in the month of August:
- Canaccord Genuity 45th Annual Growth Conference, Boston, USA, August 12-13, 2025
Fabrice Chouraqui, Chief Executive Officer, will present on Tuesday, August 12 at 12:00pm EDT/18:00 CEST.
For more information about this conference, or to schedule a one-to-one meeting with Pharming鈥檚 management team, please contact Pharming鈥檚 Investor Relations team at or your Canaccord Genuity representative.
About Pharming Group N.V.
Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. We are commercializing and developing a portfolio of innovative medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific.
For more information, visit and find us on .
For further public information, contact:
Pharming Group, Leiden, the Netherlands
Michael Levitan, VP Investor Relations & Corporate Communications
T: +1 (908) 705 1696
E:
FTI Consulting, London, United Kingdom
Simon Conway/Alex Shaw/Amy Byrne
T: +44 203 727 1000
LifeSpring Life Sciences Communication, Amsterdam, the Netherlands
Leon Melens
T: +31 6 53 81 64 27
E:
Attachment
FAQ
When is Pharming Group (PHAR) presenting at the Canaccord Genuity Growth Conference 2025?
How can investors schedule meetings with Pharming Group management at the Canaccord conference?
Where is the Canaccord Genuity Growth Conference 2025 being held?
Who will be presenting for Pharming Group at the Canaccord conference?
